Professor of Neurology and Oncology Consultant Mayo Clinic Florida
Oncology
Dr. Kurt A. Jaeckle, MD
|
|
Give Review
Kurt Jaeckle is an expert in the field of Oncology. He attended Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine Kurt Jaeckle is a published doctor. He published 32 publications, including: 'Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.
- A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.
- Oligodendroglial Tumors.
- Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.
- A randomized trial of bevacizumab for newly diagnosed glioblastoma.
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial.
- Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial.
- Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074.
- Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious ...
- North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination with Radiation Therapy in Patients with Newly Diagnosed...
- Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.
- Neurologic manifestations of neoplastic and radiation-induced plexopathies.
- Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma.
- Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.
- Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central Cancer treatment group study.
- Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group...
- Pathway analysis of primary central Nervous system lymphoma.
- Is there an association between meningioma and hormone replacement therapy?
- Status epilepticus in patients with CNS metastases.
- The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme.
- Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma.
- Neoplastic meningitis from Systemic malignancies: diagnosis, prognosis and treatment.
- Removal of an orbital metallic foreign body to facilitate magnetic resonance imaging: technical case report.
- Nonconvulsive status epilepticus in metastatic CNS disease.
- Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response.
- Improving the outcome of patients with leptomeningeal Cancer: new clinical trials and experimental therapies.
- Neurological manifestations of neoplastic and radiation-induced plexopathies.
- Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Tr...
- Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
- Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic Gliomas.
- Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.
Schools
Indiana University School Of Medicine
Vanderbilt University Hospital
Meml Sloan Kettering Center
Vanderbilt University
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Ataxia
- Bell's Palsy
- Brachial Plexus Palsy
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Neurology
- Oncology
Accepted Insurances
- Choice Plus POS II
- AvMed
- Blue Card PPO
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Golden Rule
- Humana
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
Education
-
Memorial Sloan-Kettering Cancer Center -
Vanderbilt University -
Indiana University School of Medicine
Hospital
-
Mayo Clinic - Jacksonville, Florida
Drug Facts
| NPI NUMBER | 1205825650 | |
| NPPES Provider LastName | JAECKLE | |
| NPPES Provider FirstName | KURT | |
| NPPES Provider ZIPCode | 322241865 | |
| NPPES Provider State | FL | |
| Specialty Description | Neurology | |
| Total Claim Count | 399.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1205825650 |
| Last Name Of The Provider | JAECKLE |
| First Name Of The Provider | KURT |
| View All |
Similar Doctors
|
|
Iris V. Marin Collazo |
|
|
Dr. Taimur Sher, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terrance L. Pyles, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Hank C. Hill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Capobianco, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Daniel B. Groblewski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William P. Cheshire Jr., MD |
|
Dr. Anika Goel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea M. Harriott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey B. Peel, MD |
|
|
Dr. Julia B. Whitlock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rocio Vazquez Do Campo, MD |